CSE’s Barrington Miller recently chatted with Iris Bincovich, the CEO of InnoCan Pharma Corporation (CSE:INNO) to discuss their recent patent application. In this chat, Iris shares how her team is designing CBD-loaded exosomes for targeting Coronavirus infected lung cells (2:15), how to improve CBD delivery through an injectable solution (7:53), and her prospects concerning a second wave of the virus later in the year (9:48).
A special “Cannabis Week” presentation, CSE’s Anna Serin was joined by CSE CEO Richard Carleton and special guest Bruce Campbell, Founder and Portfolio Manager at StoneCastle Investment Management Inc., to recap the (brief) history of the cannabis industry in the Canadian markets, and lend their insights from the front lines of this rapidly evolving industry.
From this chat, the insights shared include Richard’s recollection of how the CSE became a key proponent of the industry some six-years(!) ago (1:19), the one-factor that triggered Bruce to lean into the once-in-a-lifetime investment opportunity presented by cannabis deregulation (7:06), and reflections on the state of the industry before the global pandemic arrived (13:56).
Listen until the end to hear Richard and Bruce’s musing on how starting a cannabis company is like buying a golf course, the impact of COVID-19 on domestic and international cannabis operators, and the growing pains that indicate that the industry still offers opportunity amidst the ongoing business and macro risks of the day.
Disclaimer: The views, information, or opinions expressed during the podcast are solely those of the individuals involved and do not necessarily represent those of the Canadian Securities Exchange and its employees.
StoneCastle Investment Management Inc. Legal Notice
Related Links
stonecastlefunds.ca
CSE’s Barrington Miller is rejoined by Alan Brochstein, founder of 420 Investor and contributor to New Cannabis Ventures, to discuss the recent issues surrounding the cannabis industry, with a specific focus on what’s happening in the United States and in the stock market.
In this wide-ranging discussion, Alan shares what he thinks are the two major “potholes” on the road to U.S. legalization (3:32), the issues presented by capital constraints in a booming business segment (7:04), the benefits for those that survive the current pandemic crisis in cannabis (10:39), and the industry’s transition from stigmatization to essential service (14:13).
Listen until the end to hear Alan’s thoughts on why banking and research are the next two issues that need to be addressed (18:39), the one mistake investors in U.S. cannabis routinely make (21:14), his biggest cannabis-related disappointment during the pandemic (22:27), the best (and worst) State cannabis rollouts (23:25), why it was important for the industry to shift away from ‘vertical integration’ (30:28), and how the industry will evolve through COVID-19.
Related Links
420 Investor
New Cannabis Ventures
Disclaimer: The views, information, or opinions expressed during the podcast are solely those of the individuals involved and do not necessarily represent those of the Canadian Securities Exchange and its employees.
CSE’s Barrington Miller was recently joined by Christopher Moreau, CEO of Algernon Pharmaceuticals Inc. (CSE:AGN), to discuss his company’s work to develop NP-120 (Ifenprodil) as a new therapeutic in the fight against COVID-19.
In this discussion, Chris outlines how his company focuses on drug re-purposing, a term that is widely understood through the example provided by Viagra (1:04), the important distinction between therapeutic treatments and anti-virals and vaccines (12:14), and why the “grandaddy” of all market approvals is from the USFDA (18:25).
Listen until the end to hear how the company’s name is actually inspired by the title of a science fiction novel, and how the company has a history of investigating compounds developed by the Soviet Union!
(Subsequent to this chat, Algernon announced Health Canada approval to move forward with its PH2b/3 trial here with Ifenprodil as a potential treatment for COVID-19.)
Related Link
algernonpharmaceuticals.com
CSE’s Anna Serin was recently joined by Andrew Nelson, Partner at GNA Financial Advisors Inc., to discuss the many factors involved when evaluating investment opportunities in the mining sector. This wide-ranging discussion pulls generously from Andrew’s investment banking experience in finance and capital markets and serves as a great primer for those new to investing in the space.
In this chat, Andrew describes the “lifeblood” of companies when they are raising new capital (3:17), the pillars of crafting “digestible” messaging for prospective mining sector investors (6:12), and the two key variables that can combine to create exponential value for a mining stock (14:30).
Listen until the end to hear Andrew’s very simple strategy for starting a mining portfolio, his debunking of mining industry stereotypes, and the prospects for gold investing during the COVID-19 pandemic.
Related Links:
gnafinancialadvisors.com
CSE’s Phillip Shum recently chatted with Terry Howlett, CEO at Ovation Science Inc. (CSE:OVAT), to discuss the company’s current developments in the midst of the COVID-19 pandemic.
In this discussion, Terry discusses his company’s alcohol-free solution to hand-sanitization (1:11), how the DermSafe product was utilized by the Canadian Olympic teams during the most recent two Games (5:20), and the geographic demand for the product in light of the pandemic (9:24).
Listen until the end to hear how their flagship product provides 4-hour protection against germs and how it may be a key tool as society reopens in the coming months.
On this very special edition of #HashtagFinance, CSE’s Anil Mall and James Black are joined by legendary comedian – and entrepreneur – Howie Mandel, to discuss how he is coping with quarantine life, his charitable collaboration with Trevor Doerksen and ePlay Digital (CSE:EPY) and much (much) more.
In this conversation, Howie shares how his reputation as a germaphobe dovetailed into the game “Outbreak”, which evolved into a charitable tool to outfit PPE to frontline health-care workers (7:05), how technology can be a catalyst for powering the next generation of small business (and comedy) (11:24), and his simple – yet powerful – views on investing in the stock market (24:38).
Listen until the end to hear Howie’s big vision for Just for Laughs (he owns a partnership stake), how he embraces technological innovation, and his encouragement for everyone to stop overthinking and “Just Do It”.
Related Links:
www.howiesgames.com
talkshop.live
www.eplaydigital.com
#HashtagFinance is now on the left coast! Meet your west coast hosts, CSE’s Anna Serin and Anil Mall.
CSE’s Barrington Miller recently caught-up with NexTech AR Solutions Corp. (CSE:NTAR) CEO Evan Gappelberg to discuss his company’s current state of operations during the Coronavirus outbreak in NYC.
During this discussion, Evan provides commentary on the (positive) impact that the pandemic is having on his business (1:19), how their AR (augmented reality) technology fits within the shop-from home-paradigm (4:43), and his prospects for the stock market and predicted timeline for recovery (15:18).
Listen to the entire show to learn about Evan’s past history with Grand Theft Auto (the video game) and his positive experience taking a company public on the Canada Securities Exchange.
CSE’s Anna Serin was joined for a Friday edition of “Westcoast Wednesday” with Anthony Sandler, Investment Advisor at Mackie Research Capital Corporation.
In this wide-ranging conversation, Anthony shares his market insights including the economic and market impacts of not knowing how long the Coronavirus pandemic will last (3:12), specific advice for investing in SMEs (10:24), and his prospects for the cannabis space during these uncertain times (12:20).
Listen until the end to hear Anthony’s advice on how to watch the market and gather information, and his predictions for growth sectors during the “next” economic cycle.
Disclaimer
The information provided on this podcast is for informational purposes only and is not intended to provide specific financial, investment legal, tax or accounting advice and should not be relied upon as such. The contents of this podcast are not a solicitation to buy or sell securities. Mackie Research Capital Corp. is regulated by the Investment Industry Regulatory Organization of Canada and is a member of Canadian Investor Protection Fund.
